Technology
Health
Medical

Daxor

$14.26
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.61 (4.47%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Daxor and other stocks, options, ETFs, and crypto commission-free!

About

Daxor Corporation, also called Daxor, is a biotechnology company which develops and manufactures BVA-100 blood volume analyzer, an instrument that measures human blood volume. Its IDANT division provides autologous blood storage; and andrology services, such as semen analysis, sperm washing and general lab testing. Read More The company was founded by Joseph Feldschuh in 1970 and is headquartered in New York, NY.

Employees
Headquarters
New York, New York
Founded
1970
Market Cap
51.14M
Price-Earnings Ratio
Dividend Yield
0.37
Average Volume
91.09K
High Today
$14.48
Low Today
$13.85
Open Price
$13.93
Volume
7.25K
52 Week High
$19.95
52 Week Low
$4.30

Collections

Technology
Health
Medical
Biotechnology
US
North America

News

Seeking AlphaFeb 22

Daxor's BVA-100 demonstrates ease of use in critically ill patients

Daxor (DXR) is up 2% in response to new research supporting the value proposition of its BVA-100 test. The results were presented at Society of Critical Care Medicine Congress in San Diego. Recent studies showed 97% agreement between one (BVA-100) and five blood draws in critically ill patients and that BVA-100 was the most accurate way to establish blood volume. Reducing blood sampling will result in more rapid reporting of test results with a corresponding reduction in the quantity of blood sampled, tec...

48

Earnings

Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
Actual
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.